Brii Biosciences Revenue
Biotechnology Research • 
Durham, North Carolina, United States • 51-100 Employees
Brii Biosciences revenue & valuation
| Annual revenue | $3,500,000 |
| Revenue per employee | $41,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,200,000 |
| Total funding | $155,000,000 |
Key Contacts at Brii Biosciences
Ankang Li Phd Cfa
Executive Director, Chief Financial And Strategy Officer
Zhi Hong
Co-Founder And Ceo
Yao Zhang
Executive Director Of Clinical Research
Dongbiao Shen
Executive Director, Head Of Legal
Maya Brannan
Director, Senior Hr Business Partner
Lingjia Tang
Senior Director, Finance
Yun Ji
Senior Director, Immunology Research
Ellee De Groot
Chief Technology Officer
Ryan Xu
Associate Director, Procurement
Chasity Andrews
Senior Director, Business Development & Alliance Management
Company overview
| Headquarters | 110 N Corcoran St, Suite 05-110, One City Center, Durham, North Carolina 27701, US |
| Phone number | +19192405605 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology |
| Employees | 51-100 |
| Socials |
Brii Biosciences Email Formats
Brii Biosciences uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@briibio.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@briibio.com | 60% |
{first name}.{last name} | john.doe@briibio.com | 34.5% |
{last name} | doe@briibio.com | 3.6% |
{first initial}.{second initial}{last name} | j.odoe@briibio.com | 1.8% |
About Brii Biosciences
Brii Biosciences is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice. Led by a visionary and experienced leadership team, Brii Bio has deep scientific expertise and a proven ability to progress therapeutic assets from discovery to commercial approval on a consolidated timeline. Established in 2018, Brii Bio now has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Brii Biosciences has 35 employees across 11 departments.
Departments
Number of employees
Brii Biosciences Tech Stack
Discover the technologies and tools that power Brii Biosciences's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Hosting
Webmail
Security
JavaScript graphics
JavaScript libraries
UI frameworks
Analytics
Documentation
JavaScript libraries
United Kingdom
Spain
Brazil
Canada
Frequently asked questions
4.8
40,000 users
